• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Perforation (2001); Pneumonia (2011); Obstruction/Occlusion (2422); Post Traumatic Wound Infection (2447); Rectal Anastomotic Leakage (4482)
Event Date 09/08/2017
Event Type  Injury  
Event Description
Kit-man ho, 2017 ¿ colonic self-expanding metal stent (sems) as a bridge to surgery in left-sided malignant colonic obstruction: an 8-year review.We used through-the-scope stenting with niti-s uncovered colorectal stents (taewoong medical) in 58 patients, while colonic controlled-release stents (cook medical evolution) were used in the remaining four patients.Under fluoroscopic guidance.Fluoroscopy was available in the endoscopy suite during office hours.The procedure was performed by three colorectal surgeons who were experienced with stenting.A routine abdominal x-ray was taken 24 h after the intervention.Patients who consented to colonic stenting when fluoroscopy was available comprised the stenting group.Clinical success was defined as the resolution of obstructive symptoms within 72 h after the procedure with passage of stool [10].Upon resolution of the intestinal obstruction, patients underwent optimization of their medical condition and thorough oncological workup, including a ct scan of the thorax, abdomen and pelvis if these had not been performed before stenting.Multiple ae's described which could have potentially been associated with cook device however not confirmed: pneumonia (2), ileus (1), recurrent intestinal obstruction requiring operation (2), anastomotic leakage (2), abdominal collections (2), stent perforations (5), one patient did not have resolution of the obstructive symptoms even after successful stent deployment (stent occlusion) (1).
 
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Supplemental report being submitted due to clinical input received on 09-jan-24 which has determined some ae's previously reported under (emdr # 3001845648-2024-00020) were not caused / contributed to by the cook device.As per clinical input on 09-jan-24, the following were deemed to be a 'complication after surgery.And irrelevant to stent placement and stent indwelling': pneumonia (2), ileus (1), recurrent intestinal obstruction requiring operation (2), anastomotic leakage (2), abdominal collections (2).The description of the event will now only capture the following having been potentially caused / contributed to by the device: five stent perforations (5), one patient did not have resolution of the obstructive symptoms even after successful stent deployment.(1).Updated description of event and updates to annex e codes: kit-man ho, 2017 ¿ colonic self-expanding metal stent (sems) as a bridge to surgery in left-sided malignant colonic obstruction: an 8-year review.We used through-the-scope stenting with niti-s uncovered colorectal stents (taewoong medical) in 58 patients, while colonic controlled-release stents (cook medical evolution) were used in the remaining four patients.Under fluoroscopic guidance.Fluoroscopy was available in the endoscopy suite during office hours.The procedure was performed by three colorectal surgeons who were experienced with stenting.A routine abdominal x-ray was taken 24 h after the intervention.Patients who consented to colonic stenting when fluoroscopy was available comprised the stenting group.Clinical success was defined as the resolution of obstructive symptoms within 72 h after the procedure with passage of stool [10].Upon resolution of the intestinal obstruction, patients underwent optimization of their medical condition and thorough oncological workup, including a ct scan of the thorax, abdomen and pelvis if these had not been performed before stenting.Two ae's described which could have potentially been associated with cook device however not confirmed: stent perforations (5) one patient did not have resolution of the obstructive symptoms even after successful stent deployment (stent occlusion) (1).
 
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key18455484
MDR Text Key332203916
Report Number3001845648-2024-00020
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Reporter Country CodeHK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/08/2017
Event Location Hospital
Date Manufacturer Received12/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexMale
-
-